Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 27 February 2017
Kuros receives clearance from the US FDA for MagnetOs allowing marketing in the United States
Press Release, 8 February 2017
Kuros achieves ISO certification for surgical sealants
Press Release, 25 January 2017
Kuros closes acquisition of Xpand creating a leading commercial-stage orthobiologics company
Press Release, 21 December 2016
Kuros submits regulatory filing seeking CE certification for Neuroseal, a novel dural sealant
Press Release, 19 December 2016
Kuros to acquire Xpand in an all-share strategic transaction to create a leading commercial stage orthobiologics company
Press Release, 20 October 2016
Kuros Biosciences' KUR-112 Receives Rare Pediatric Disease Designation